Pmgc Holdings Inc (ELAB) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Pmgc Holdings Inc   (NASDAQ: ELAB)


Pmgc Holdings Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELAB Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change -
Seq. Revenue Change 91.59 %
Revenue In Millions $1.31
Gross Profit Margin 21.01 %
Gross Profit Margin Total Ranking # 2347
Gross Profit In Millions $0.27
Y / Y Gross Profit Change -
Seq. Gross Profit Change 19.08 %


Commenting Second Quarter 2026 Gross Profit Margin
Pmgc Holdings Inc has managed to improve its Revenue sequentially to $1.31 millions by 91.59 % faster than Gross Profit increase of 19.08 % to $0.27 millions, this led to contraction in Gross Profit Margin to 21.01 %, a new company low.


Observing second quarter 2026 results within Major Pharmaceutical Preparations industry 126 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2347, from total ranking in the previous quarter at 2498.
Learn about Gross Margin
ELAB's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 127
Healthcare Sector # 370
Overall # 2328

Gross Profit Margin Statistics
High Average Low
74.68 % 53.9 % 21.01 %
(Sep 30 2024)   (Jun 30 2026)


ELAB Gross Income Trends • More of ELAB's Profitabilty Ratios • ELAB Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ELAB's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ELAB's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ELAB's Competitors
Gross Profit Margin Profit Margin for Pmgc Holdings Inc 's Suppliers
Gross Profit Margin Profit Margin for ELAB's Customers

You may also want to know
ELAB's Annual Growth Rates ELAB's Profitability Ratios ELAB's Asset Turnover Ratio ELAB's Dividend Growth
ELAB's Roe ELAB's Valuation Ratios ELAB's Financial Strength Ratios ELAB's Gross Profit Growth
ELAB's Roa ELAB's Inventory Turnover Ratio ELAB's Growth Rates ELAB's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Siga Technologies Inc  57.17 %$ 23.441  Millions$ 41.002  Millions
Schrodinger Inc   55.07 %$ 32.432  Millions$ 58.889  Millions
Zai Lab Limited  54.70 %$ 58.149  Millions$ 106.311  Millions
Mallinckrodt Plc  54.52 %$ 282.000  Millions$ 517.200  Millions
International Stem Cell Corporation  54.50 %$ 1.458  Millions$ 2.675  Millions
Organon and Co   54.36 %$ 847.000  Millions$ 1,558.000  Millions
Teva Pharmaceutical Industries Limited  51.98 %$ 2,153.000  Millions$ 4,142.000  Millions
Prestige Consumer Healthcare Inc   51.25 %$ 136.188  Millions$ 265.710  Millions
Amphastar Pharmaceuticals Inc   50.83 %$ 93.470  Millions$ 183.903  Millions
Bullfrog Ai Holdings Inc   49.63 %$ 0.107  Millions$ 0.215  Millions
Opko Health Inc   48.92 %$ 80.017  Millions$ 163.580  Millions
Cv Sciences Inc   48.58 %$ 1.450  Millions$ 2.985  Millions
Cryoport inc   46.61 %$ 22.824  Millions$ 48.971  Millions
Bausch Health Companies Inc   45.86 %$ 1,308.000  Millions$ 2,852.000  Millions
Amneal Pharmaceuticals Inc   42.01 %$ 334.508  Millions$ 796.197  Millions
Collegium Pharmaceutical Inc   41.86 %$ 83.659  Millions$ 199.878  Millions
Elite Pharmaceuticals Inc   41.75 %$ 13.508  Millions$ 32.355  Millions
Maravai Lifesciences Holdings Inc   40.14 %$ 20.650  Millions$ 51.442  Millions
Viatris Inc   38.77 %$ 1,456.500  Millions$ 3,756.800  Millions
Nrx Pharmaceuticals Inc   38.69 %$ 0.426  Millions$ 1.101  Millions
Amarin Corp Plcuk  35.30 %$ 14.989  Millions$ 42.460  Millions
Phibro Animal Health Corporation  33.88 %$ 134.401  Millions$ 396.747  Millions
Perrigo Company Plc  30.69 %$ 313.900  Millions$ 1,022.800  Millions
60 Degrees Pharmaceuticals Inc   27.32 %$ 0.057  Millions$ 0.208  Millions
Sunshine Biopharma Inc   26.20 %$ 2.427  Millions$ 9.264  Millions
Blue Water Vaccines Inc  25.13 %$ 0.004  Millions$ 0.017  Millions
Newamsterdam Pharma Company N v   24.86 %$ 0.920  Millions$ 3.701  Millions
Prophase Labs Inc   22.35 %$ 0.226  Millions$ 1.011  Millions
Pmgc Holdings Inc   21.01 %$ 0.274  Millions$ 1.307  Millions
Aspire Biopharma Holdings Inc   19.47 %$ 0.012  Millions$ 0.063  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.